Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ketty Peris

Showing results (401-410 of 533) with videos related to

Pageof 54
Sort By:
Dermatology (Basel, Switzerland)|February 8, 2023
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the DifferenceMaria Concetta Fargnoli, Paolo Antonetti, Laura Atzori, et al.
Expert Opinion on Biological Therapy|July 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in ItalyArianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, et al.
Dermatologic Therapy|July 11, 2020
Italian expert consensus paper on the management of patients with actinic keratosesElvira Moscarella, Eugenia Veronica Di Brizzi, Alice Casari, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 31, 2025
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort StudyGianluca Avallone, Luca Valtellini, Gianluca Tavoletti, et al.
The Journal of Dermatological Treatment|June 9, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?Edoardo Mortato, Niccolò Gori, Giacomo Caldarola, et al.
Dermatology (Basel, Switzerland)|June 13, 2023
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and EffectivenessMaria Mannino, Alfredo Piccerillo, Gabriella Fabbrocini, et al.
European Journal of Dermatology : EJD|January 10, 2018
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinicsMaria Concetta Fargnoli, Gianfranco Altomare, Elisa Benati, et al.
Dermatology (Basel, Switzerland)|April 23, 2025
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive AreasNiccolò Gori, Marco Galluzzo, Andrea Chiricozzi, et al.
Journal of Cutaneous Medicine and Surgery|April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDTPiergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
American Journal of Clinical Dermatology|March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational StudyCataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Pageof 54

Showing results (401-410 of 533) with videos related to

Sort By:
Pageof 54
Dermatology (Basel, Switzerland)|February 8, 2023
"Your Skin Tells You" Campaign for Keratinocyte Cancers: When Individuals' Selection Makes the DifferenceMaria Concetta Fargnoli, Paolo Antonetti, Laura Atzori, et al.
Expert Opinion on Biological Therapy|July 19, 2021
Predictive factors of lack of response to adalimumab among bio-naive patients suffering from moderate-to severe psoriasis: analysis of a multicenter data collection in ItalyArianna Zangrilli, Giacomo Caldarola, Nicoletta Bernardini, et al.
Dermatologic Therapy|July 11, 2020
Italian expert consensus paper on the management of patients with actinic keratosesElvira Moscarella, Eugenia Veronica Di Brizzi, Alice Casari, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 31, 2025
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort StudyGianluca Avallone, Luca Valtellini, Gianluca Tavoletti, et al.
The Journal of Dermatological Treatment|June 9, 2025
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?Edoardo Mortato, Niccolò Gori, Giacomo Caldarola, et al.
Dermatology (Basel, Switzerland)|June 13, 2023
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and EffectivenessMaria Mannino, Alfredo Piccerillo, Gabriella Fabbrocini, et al.
European Journal of Dermatology : EJD|January 10, 2018
Prevalence and risk factors of actinic keratosis in patients attending Italian dermatology clinicsMaria Concetta Fargnoli, Gianfranco Altomare, Elisa Benati, et al.
Dermatology (Basel, Switzerland)|April 23, 2025
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive AreasNiccolò Gori, Marco Galluzzo, Andrea Chiricozzi, et al.
Journal of Cutaneous Medicine and Surgery|April 14, 2017
Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDTPiergiacomo Calzavara-Pinton, Merete Hædersdal, Kirk Barber, et al.
American Journal of Clinical Dermatology|March 16, 2021
Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational StudyCataldo Patruno, Gabriella Fabbrocini, Giuseppe Longo, et al.
Pageof 54